☀️     🌓

Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

SMC Update - December 2023

December 12, 2023 at 9:32 am | In Prescribing Extra - Drugs | Print Print | No Comments

The Scottish Medicines Consortium (SMC) has issued its monthly advice on newly licensed medicines.

Osilodrostat (Isturisa®) has been rejected for use in the treatment of endogenous Cushing’s syndrome in adults. The manufacturer failed to make a submission for this indication. In considering the product license, it would be expected that this medicine would be prescribed and monitored by a specialist.

Action: Clinicians should be aware of the recommendations of the SMC. Routine use of rejected and restricted medicines should be avoided.

Share 'SMC Update - December 2023' by emailShare 'SMC Update - December 2023' on FacebookShare 'SMC Update - December 2023' on TwitterShare 'SMC Update - December 2023' on MastodonShare 'SMC Update - December 2023' on LinkedInShare 'SMC Update - December 2023' on reddit

Copyright © 2023 Prescribing Advice for GPs

No Comments to “SMC Update - December 2023”

Leave a Comment

Your email address will not be published. Required fields are marked *

Please be aware that you comment is subject to our Privacy Policy.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Prescribing Advice for GPs is powered by ClassicPress.
Connect to our RSS or Atom Feeds.